simulations of peptide aggregation
DESCRIPTION
Simulations of Peptide Aggregation. Joan-Emma Shea Department of Chemistry and Biochemistry The University of California, Santa Barbara. Protein and Peptide Aggregation. PROTEIN AGGREGATION AND DISEASE. Parkinson. Alzheimer. Prion (“Mad Cow”). Huntington. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/1.jpg)
Simulations of Peptide Aggregation
Joan-Emma Shea
Department of Chemistry and BiochemistryThe University of California, Santa Barbara
![Page 2: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/2.jpg)
Protein and Peptide Aggregation
![Page 3: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/3.jpg)
PROTEIN AGGREGATION AND DISEASE
Alzheimer
Huntington
Parkinson
Prion(“Mad Cow”)
Proteins not associated with a specific disease can also aggregate to form amyloid fibrils
![Page 4: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/4.jpg)
APPLICATION TO BIOMATERIALS
Nano-tube and nano-sphere fabrication using aromatic di-peptides. [Gazit et al., Nano Lett, 4 (2004) 581]
Use of peptides to form nanoscale-ordered monolayers, COSB 2004, 14: 480
![Page 5: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/5.jpg)
Time scalesSide-chain rotations
Loop closure
Helix formation Folding of-hairpins
Protein folding
Protein aggregation
![Page 6: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/6.jpg)
All-atom: MolecularDynamics (MD)With EXPLICIT Solvent
MULTISCALE APPROACH
Off-lattice minimalist:Langevin dynamics
All-atom: MolecularDynamics (MD) withIMPLICITsolvent
COARSE GRAINING
![Page 7: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/7.jpg)
1. Dimerization Mechanisms of 4 tetrapeptides KXXE
2. Design of Inhibitors of aggregation of the AlzheimerAmyloid-beta (A) peptide.
Fibrilsof KFFE
![Page 8: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/8.jpg)
KXXE peptides
Tjernberg et al. , JBC 277 (2002) 43243
KAAE
KVVE KFFE
KLLE
Fibrils!
![Page 9: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/9.jpg)
PEPTIDE MODEL
CHARMM19 Force Field and Generalized Born Implicit Solvent
1010
54)(
RrRrr
RerU pc
R
ep=1 kCal/mol, =1Å,
R=17Å
Confining Sphere:
![Page 10: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/10.jpg)
NVTNVTT1
TN
T2
))((,1min mnij EEe
Simulation protocol: Replica Exchange MD6 replicas for monomer: total simulation time: 40 ns12 replica for dimers: total simulation time: 400 ns
![Page 11: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/11.jpg)
Heterogeneous dimers
RMSD (Å)
E (
kC
al/m
ol)
![Page 12: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/12.jpg)
Association temperature Ta
KFFE > KVVE > KLLE > KAAE
Thermodynamicstability of dimers:
Aa
La
Va
Fa TTTT
![Page 13: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/13.jpg)
What determines transition temperature Ta?
Ta=
SU / translconfig SS
Propensity for structureSalt bridgesHydrophobic contactsAromatic interactions
monomererchain UU int
![Page 14: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/14.jpg)
T=325K
T=240K T=275K
Free energy as a function of interaction energy and radius of gyration
T=285K
U (kCal/mol)
Rg
(Å
)
U
UU
![Page 15: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/15.jpg)
T=325K
T=240K T=275K
Free energy as a function of interaction energy and radius of gyration
T=285K
U (kCal/mol)
Rg
(Å
)
U
UU
Interaction energy: KFFE > KLLE ~ KVVE > KAAE
Most favorable
Least favorable
![Page 16: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/16.jpg)
Entropy loss due to dimerization
Monomers, Rg>5A
-strand
RandomCoil
Helix
![Page 17: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/17.jpg)
Entropy loss due to dimerization
Monomers, Rg>5A
-strand
RandomCoil
Helix
![Page 18: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/18.jpg)
Entropy loss due to dimerization
Monomers, Rg>5A Dimers, Rg<5A
-strand
RandomCoil
Helix
![Page 19: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/19.jpg)
Entropy loss due to dimerization
Monomers, Rg>5A Dimers, Rg<5A
-strand
RandomCoil
Helix
-strand basin more populated for monomerof KVVE than KLLE: SL > SV
![Page 20: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/20.jpg)
Association temperature
SUTa /
Energetic effect
Entropic effect
FVAL SSSS
ALVF UUUU ~
Aa
La
Va
Fa TTTT
![Page 21: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/21.jpg)
KFFE KLLE
Kinetic accessibility of dimers
E (Kcal/mol) E (Kcal/mol)
Rg
(Å
)
KFFE KLLE
“DOWNHILL” DIMERIZATION FOR KFFE
FREE ENERGY BARRIERFOR KLLE
![Page 22: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/22.jpg)
Different mechanisms of dimerization
PHE-PHE come together first (stabilized by vdw interactions), followed by the overall collapse of the structure with formation of peptide backbones contacts .
Rg
ove
r C
Rg over PHE atoms Rg over LEU atoms
LEU side chain formation and overall collapse with formation ofpeptide backbone interactions occur simultaneously.
KFFE KLLE
![Page 23: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/23.jpg)
CONCLUSIONS
Aa
La
Va
Fa TTTT for dimerization of the
KXXE peptides1.
2. Strong sequence dependence of free energy landscapes for dimerization, with KFFE experiencing a barrierless transition.
3. KFFE dimers are the most thermodynamically stable and kinetically accessible.
4. Dimer trends match experimental trends observed for fibrils.
![Page 24: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/24.jpg)
Aβ40: DAEFRHDSGYEVHHQ16KLVFFA22EDVGSNKGAIIGLMVGGVV
Aβ42: DAEFRHDSGYEVHHQ16KLVFFA22EDVGSNKGAIIGLMVGGVVIA
LARGER SYSTEMS: OLIGOMERIZATION OF THE ALZHEIMER AMYLOID BETA (A) PEPTIDES
AMYLOID BETA (A) PEPTIDES AGGREGATE TO FORM TOXIC OLIGOMERS AND FIBRILS
![Page 25: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/25.jpg)
Aβ40: DAEFRHDSGYEVHHQKLVFFAEDV25GSNKGAIIGL35MVGGVV
FRAGMENT 25-35 OF THE (A) PEPTIDE APPEARS TO BETOXIC IN MONOMERIC, SMALL OLIGOMERIC AND FIBRILLAR FORMS
NO STRUCTURE OF THE MONOMERIC PEPTIDE AVAILABLE IN AQUEOUS SOLVENT
PEPTIDE ADOPTS A HELICAL STRUCTURE IN APOLARORGANIC SOLVENT (SUCH AS HEXAFLUOROISOPROPANOL HFIP)
![Page 26: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/26.jpg)
EFFECTS OF SOLVENT ON FREE ENERGY LANDSCAPE OF THE MONOMER
REPLICA EXCHANGE SIMULATION IN:
1) HFIP/WATER CO-SOLVENT 2) PURE WATER
GROMOS96 FORCE FIELD, EXPLICIT SOLVENT
40 REPLICAS, 16 NS EACH, TOTAL SIMULATION TIME OF 640 NS
![Page 27: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/27.jpg)
FREE ENERGY SURFACE IN HFIP/WATER COSOLVENT:
HELIX STABILIZATION
T=300 K
45 %
8%
N
N
N
N
C
CC
C
![Page 28: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/28.jpg)
HFIP DISPLACES WATER NEAR THE PEPTIDE, AND FORMS A “COAT” AROUND THE PEPTIDE
![Page 29: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/29.jpg)
FREE ENERGY SURFACE IN PURE WATER
FORMATION OF COLLAPSED-COILS and -HAIRPINS
T=300K
N
N
N
N
N C
C
C
C
C
![Page 30: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/30.jpg)
Possible importance of turn in toxicity of monomer
![Page 31: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/31.jpg)
REPLICA EXCHANGE MD ON DIMERS IN WATER:HETEROGENEOUS DIMERS
![Page 32: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/32.jpg)
TWO TYPES OF ORDERED DIMERS
Experimentally: two different protofilament of diameters:1.41 +/- 0.48 nm3.58 +/- 1.53 nm
![Page 33: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/33.jpg)
PEPTIDE INHIBITORS OF ALZHEIMER A AGGREGATION
Alzheimer’s disease (AD) is a neurodegenerative disease of the central nervous system.
![Page 34: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/34.jpg)
ALZHEIMER DISEASE IS CHARACTERIZED BY THEPRESENCE OF NEUROFIBRILLAR TANGLES AND
AMYLOID PLAQUES IN THE BRAIN
![Page 35: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/35.jpg)
Aβ40: DAEFRHDSGYEVHHQ16KLVFFA22EDVGSNKGAIIGLMVGGVV
Aβ42: DAEFRHDSGYEVHHQ16KLVFFA22EDVGSNKGAIIGLMVGGVVIA
AMYLOID PLAQUES CONSIST OF AMYLOID BETA (A) PEPTIDES GENERATED FROM THE PROTEOLYTIC CLEAVAGE OF THE APP TRANSMEMBRANE PROTEIN
![Page 36: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/36.jpg)
Amyloid Plaques
Aβ40: DAEFRHDSGYEVHHQ16KLVFFA22EDVGSNKGAIIGLMVGGVV
Aβ42: DAEFRHDSGYEVHHQ16KLVFFA22EDVGSNKGAIIGLMVGGVVIA
In healthy individuals, the A peptides are broken down and eliminated. In AD, these peptides self-assemble into amyloid fibrils
Fibril
![Page 37: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/37.jpg)
Both small soluble oligomers and fibrils appear to be toxic to cells.
Native Protein
Misfolded Protein
Soluble Oligomer
Protofibrils
Fibril
![Page 38: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/38.jpg)
N-methylated A(16-20)m peptides can:1) prevent the aggregation of full length A peptide 2) disassemble existing fibrils and possibly small oligomers.
Aβ40: DAEFRHDSGYEVHHQ16KLVFFA22EDVGSNKGAIIGLMVGGVV
N-METHYLATED PEPTIDE INHIBITORS
16K(me)LV(me)FF
Fibrils ofA(1-40)peptides
After IncubationwithA(16-20)mpeptides
Meredith and co-workers, J. Pep. Res. (2002) 60, 37-55
![Page 39: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/39.jpg)
Fragment A(16-22) KLVFFAE aggregates to form fibrils
Tycko et al. Biochemistry, 39 (45), 13748 -13759, 2000
Antiparallel arrangements from solid state NMR
MODEL SYSTEM
Aβ40: DAEFRHDSGYEVHHQ16KLVFFA22EDVGSNKGAIIGLMVGGVV
![Page 40: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/40.jpg)
A(16-22) KLVFFAE PROTOFIBRIL
INITIAL STRUCTURE:
Two parallel bilayers
Peptides in layer antiparallel
lys16 and glu22 point to solvent
leu17, phe19, ala21 point inside core
![Page 41: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/41.jpg)
A(16-22) KLVFFAE PROTOFIBRIL
INITIAL STRUCTURE:
Two parallel bilayers Peptides in layer antiparallel
lys16 and glu22 point to solvent
leu17, phe19, ala21 point inside core
GROMOS96 FORCE FIELDEXPLICIT SPC WATER(23000 atoms)
REACTION FIELD/ PME TWO 20 NS SIMULATIONS
![Page 42: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/42.jpg)
REPRESENTATIVE A(16-22) PROTOFIBRIL
(LAST 7 NS OF SIMULATIONS)
Distance between bilayers: 0.93 nm (Tycko: 0.99nm)Distance between peptides: 0.44-0.52 nm (Tycko: 0.47 nm)
![Page 43: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/43.jpg)
Structure of N-methylated A(16-20)m Inhibitor Peptide
Replica Exchange Molecular Dynamics, 30 replicas,20 ns per replica
A(16-20)m more rigid than A(16-22), with -strand content:This pre-organization may allow A(16-20)m to successfullycompete with free A(16-22) for binding to fibril.
![Page 44: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/44.jpg)
Interaction of A(16-20)m Inhibitor Peptide with protofibril
INITIAL STRUCTURE
A(16-20)m with N-methyl groups pointing away fibril
A(16-20)m with N-methyl groups pointing toward fibril
![Page 45: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/45.jpg)
Interaction of A(16-20)m Inhibitor Peptide with protofibril
AFTER 50 ns
A(16-20)m with N-methyl groups pointing toward fibril
Intercalates betweenlayers
A(16-20)m with N-methyl groups pointing away fibril
Forms hydrogen bonds with fibril(antiparallel)
![Page 46: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/46.jpg)
POSSIBLE MECHANISM OF FIBRIL DISRUPTION
Inhibitor drifts from edge of fibril to side and inserts in fibril (between strands 6 and 7) with Lys pointing to solvent and hydrophobic residues inserted in fibril.
![Page 47: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/47.jpg)
POSSIBLE MECHANISM OF INHIBITION OF FIBRIL GROWTH
Inhibitor forms hydrogen bond with fibril, with antiparallelalignment, possibly preventing additional A(16-22) peptidesfrom binding.
![Page 48: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/48.jpg)
DESTABILIZATION OF FIBRIL WHEN INHIBITOR INSERTEDIN FIBRIL
Inhibitor inserted in fibril affects the “twist” of the fibriland the distance between strands.
![Page 49: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/49.jpg)
CONCLUSIONS AND FUTURE DIRECTIONS
1. Results suggest possible mechanisms of fibril inhibition and disassembly
2. Extend the simulations to consider other orientations of the inhibitor peptides
3. Study and design new inhibitors
![Page 50: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/50.jpg)
ACKNOWLEDGEMENTS
Dr. P. Soto
Other group members: M. Friedel, M. Griffin, A. Jewett, W. B. Lee and E. Zhuang
Funding: NSF Career, David and Lucile Packard Foundation, A. P. Sloan Foundation, Army Research Office.
Collaborator: Prof. Stephen Meredith, University of Chicago
Dr. G. WeiDr. A. Baumketner
![Page 51: Simulations of Peptide Aggregation](https://reader036.vdocument.in/reader036/viewer/2022062517/568135e3550346895d9d551e/html5/thumbnails/51.jpg)
University of California Santa Barbara